ADMIRAZ
DEAD

Serial Number

87558629

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 7, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ADMIRAZ Trademark

Serial Number: 87558629

ADMIRAZ is a trademark filed by NOVARTIS AG on August 7, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 7, 2017

Registration Date

Not Registered

Published for Opposition

November 7, 2017

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 2, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 2, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2021 EXRA
SOU EXTENSION 5 GRANTED
Jan 13, 2021 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 11, 2021 AITU
SOU EXTENSION 5 FILED
Dec 22, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 22, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 23, 2020 EXRA
SOU EXTENSION 4 GRANTED
Jun 21, 2020 EX4G
SOU EXTENSION 4 FILED
Jun 21, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 21, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 24, 2019 EXRA
SOU EXTENSION 3 GRANTED
Dec 22, 2019 EX3G
SOU EXTENSION 3 FILED
Dec 22, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 22, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jun 24, 2019 EX2G
SOU EXTENSION 2 FILED
Jun 24, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 24, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 26, 2018 EXRA
SOU EXTENSION 1 GRANTED
Dec 24, 2018 EX1G
SOU EXTENSION 1 FILED
Dec 24, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 24, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 26, 2018 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 17, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 7, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 7, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 18, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2017 CNSA
ASSIGNED TO EXAMINER
Sep 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2017 NWOS
NEW APPLICATION ENTERED
Aug 10, 2017 NWAP